Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
96 Cards in this Set
- Front
- Back
Fungal infections are generally associated with what parts of the body?
|
Skin (athletes foot) and mucous membranes (thrush)
|
|
What are the three categories of antifungal agents?
|
Systemic antifungal agents for systemic infections
Systemic antigfungal drugs for mucocutaneous infections and antifungal drugs for topical infections |
|
Fungal infections are fatal when?
|
When the immune system is compromised or when fungi gain access to systemic circulation
|
|
Are fungal infecitons benign or malignant?
|
benign
|
|
Cell wall synthesis?
|
Caspofungin
|
|
Membrane function
|
Aphotercin B
|
|
Nucleic Acid synthesis
|
5-fluorocytosine
|
|
Lanosterol synthesis
|
Terbinafine and Nattifine
|
|
Ergosterol synthesis
|
Fluconazole
itraconazole voriconazole |
|
What are the individual systemic antifungal agents for systemic infections?
|
Amphotercin B
Flucytosine Azoles Echinocandins |
|
What are the systemic antifungal drugs for mucocutaneous infections?
|
Griseofulvin
Terbinafine |
|
Antifungal drugs for toical infection?
|
Nystatin
topical azoles topical allyamines (terbinafine) |
|
Name some characteristics of the Amphotercin Structure
|
Lacton
conjugated double bonds |
|
amphotercin B's solubility?
|
insoluble in water, conventionall prepared as a colloid suspension for IV injection
|
|
Ampotercin category?
|
polyene macrolide
|
|
What is the neewr formation of amphotercin B?
|
Lipid-packaged
|
|
Desribe Amphotercin B's absorption
|
Poorly absorbed from the GI ( orally administered only for infection localized to GI lumen)
|
|
Amphotercin B's Distribution
|
widely distributed to most tissues, NOT in CSF
(sometimes used intrathecally for fungal meningitis) |
|
Can Amphotercin B get into CSF?
|
NO
|
|
Is Amphotercin B broad specturm or narrow spectrum?
|
Broad Spectrum
|
|
Name some fungus tha Amphotercin B kills?
|
Candida albicans
Cryptococcous neorformans, HIstoplasma capsulatum, blastomyces dermatidis, Aspergills fumigatus |
|
What is ampotercin B's MOA?
|
Binds to a sterol moiety, primarily ergosterol that is present in teh membrane of sensitive fungi. Then, forms pores or channels that increase teh permeability of the membrane, allowing leakage of a variety of small molecules
|
|
What is Amphotercin B's selectivitiy?
|
predominant sterol in mammalian membrane: cholesterol
|
|
Name the two cause of resistance to Amphotercin B?
|
Decreased fungus membrane concentration of ergosterol and modification of polyene binding site on ergosterol
|
|
What is the main cause of resistance to Amphotercin b?
|
due to impaired ergosterol binding
|
|
What are the two main drug formulation for Amphotercin B?
|
conventional formulation and lipid formulation for IV infusion
|
|
Why is Amphotercin B's partical size relevant to pharmacy?
|
Paritcle size for suspension 0.4 micrometers in diameter. IV lines are normally 0.22 micometers in diameter; therefore, you need a bigger pore size filter when giving this drug.
|
|
The conventional formulation of Amphotercin B forms a ______ in water.
|
colloid
|
|
What conventional formulatiom of Amphotercin B is named?
|
Amphotercin B deoxycholate complex (C-AMB)
|
|
How many lipid formulations are in teh US?
|
three
|
|
The lipid carrier in Amphotercin B lipid formulation serves as what?
|
Amphotercin B reservoir, which reduces binding to human cell membrane
|
|
Name in order which has a higher affinity for Amphotercin B? ergosterol, cholesterol,and lipid vehicle
|
ergosterol>lipid vehicle> cholesterol
|
|
Why is there a lipid formulation for Amphotercin B?
|
allow for reduction in toxicity, clinical efficacy only moderately increased,
|
|
What is the problem with lipid formulation of Amphotercin B?
|
very expensive
|
|
What are the infustion related toxicities of Amphotercin B?
|
fever, chills, muscle spasms, vomiting, HA, hypotension
|
|
Are infustion related toxicities immeidate onset or slow onset?
|
immediate reaction
|
|
What causes the infustion related toxicities to stop?
|
decrese daily dose or infusion rate
|
|
What are the cumulative toxicties of Amphotercin B?
|
renal damage (reversible or irreversible), heptotoxicity, and sezuires, anemia
|
|
Is flucytosine narrow spectrum or broad spectrum compared to Amphotercin B?
|
narrow spectrum
|
|
What fungus is flucytosine restricted to?
|
Crptococcus neoformans and some canidida species
|
|
How is flucytosine administered?
|
orally
|
|
Describe the absoprtion of Flucytosine.
|
well absorbed from GI
|
|
Distribution of Flucytosine?
|
Well distributed in tissue fluids, INCLUDING CSF
|
|
Elimination of Flucytosine?
|
renally
|
|
When should the dose of flucytosien be adjusted?
|
renal impairment becaues the drug is eliminated renally
|
|
What drug exhibits synergism with flucytosine?
|
Amphotercin B
|
|
Explain the synergism of Amphotercin B and flucytosine.
|
enhanced penetration of fucytosine through amphotercin B damaged membranes
|
|
To become an antifungal what does flucytosine need to be converted to?
|
5-flura uracil (5-FU)
|
|
Flucytosine is converted to___, then to ____, and further ______
|
5-fluorouracil, FdUMP, FUTP
|
|
Fucytosine inhibits?
|
DNA and RNA synthesis
|
|
Flucytosine is unable to affect human cells because?
|
human cells are unable to convert parent drug to 5-FU
|
|
Resistance of Flucytosine?
|
altered metabolism of flucytosine
|
|
What caued ADE of flucytosine?
|
due to metabolism to 5 FU
|
|
What are the ADE of flucytosine?
|
bone marrow toxicity and less frequently hepatotoxicity
|
|
Name the synthetic compounds that are derivatives of imidazoles:
|
ketoconazole
miconazole (topical) clotrimazole (topical) |
|
Synthetic compounds that are derivated of Triazoles:
|
itraconazole
fluconazole voriconazole |
|
What is the MOA of Azoles?
|
inhinit fungal p450 enzymes involved in ergosterol synthesis
|
|
What is less selective for fungal p450s?
|
imidazoles
|
|
Azoles exhibit ___ affinity for fungal than human p450 enzymes
|
greater
|
|
Are azoles broad spectrum or narrow spectrum?
|
broad spectrum
|
|
What fungus do Azoles kill?
|
Candida sp. Cryptococcus neoformans, endemic mycoses (blastomycosis, coccidiodmycosis, histoplasmosis) and Asperigillus
|
|
What are azoles prone to drug interaction?
|
effect on mammalian p450
|
|
How well tolerated are Azoles?
|
relatively well tolerated: minor GI distubrances and abnormallities in liver enzymes
|
|
What drug has the greatest propensity to inhibit mammalian p450 enzymes
|
ketoconazole
|
|
Name the two ways Itraconaole is administered?
|
Orally and IV
|
|
Does itraconazole have high or low bioavailibity?
|
low
|
|
Which azole affect mammalizan cells more than itraconazole?
|
ketoconazole
|
|
Does itraconazole perentrate into CSF?
|
penetrated poorly in CSF
|
|
Which drug has high oral bioavaiblity? itraconazoel or fluconazole
|
fluconzole
|
|
Which azole is least effet on mammalian p450s?
|
Fluconazole
|
|
Does fluconzole penetrate into CSF?
|
yes
|
|
What fungus is fluconazole not active against?
|
Asperigillus
|
|
What drug has excellent oral bioavailability?
|
Voriconazole
|
|
Name in order which has the greatest effect on mammalian cells? azole
|
Ketoconazole>itraconazole> voriconazole>fluconazole
|
|
Is voriconazole active against Asperigillus?
|
Yes
|
|
Which azole causes rash, hepatotoxicity, vision problems
|
Voriconazole
|
|
What fungus are Echinocandins active against?
|
candida and aspergillus, NOT against cryptococous
|
|
Echinocandins are large cyclic peptides attatched to ____
|
fatty acid chain
|
|
Caspofungin, MIcafungin, anidulafungini are examples of what?
|
are examples of Echinocandins
|
|
Echinocandins are adminstered?
|
IV only
|
|
What is the MOA of Echinocandins?
|
disrupt fungal cell wall (inhibit synthesis of B (1-3) glucan
|
|
What are the ADEs of Echinocandins?
|
very well tolerated; can cause minor GI disturbances and flushing
|
|
Name two drugs that are systemic antifungal for mucocuntaneous infections?
|
Griseofulvin and Terbinafine
|
|
Name the three drugs used for topical antifunal therapy?
|
Nystatin, clotrimazole, miconazole, and topical terbinafine and naftifine
|
|
Oral absorption fo Griseofulvin is improved when given with______
|
fatty foods
|
|
Explain how Griseofulvin works?
|
MOA unkown; however deposited in newly formed skin (binds to keratin and protects skin from new infection)
|
|
What are the administration requirements for Griseofulvin?
|
requireds prolonged administration
|
|
How long should Griseofulvin be givin for hair and skin infections?
|
2-6 weeks
|
|
How long should Griseofulvin be given for nail infections?
|
months
|
|
What is the MOA for terbinafine?
|
binds to keratin and interferes with erogosterol synthesis by inhibiting fungal enzyme squalene epoxidase (toxic squalene accumulates in fungi
|
|
Does terinafine affect p450?
|
no
|
|
Name the ADEs of Terbinafine:
|
well tolerated (mild GI upset)
|
|
Why is Nystatin only used orally?
|
to toxic for parental administration
|
|
What is nystatin used for?
|
candidial infections
|
|
Nystastin is not absorbed from....
|
GI, Skin, and mucous membranes
|
|
What are clotrimazole and miconazole used for?
|
Used for vuvlvovaginal candidiasis and dermatophytic infections
|